{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2016-N-2527\" sorted by posted_date descending", "rows": [["FDA-2016-N-2527-8031", "FDA", "FDA-2016-N-2527", "Exhibit E-3 - Appendix B to Citizen Petition re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T15:02:42Z", null, 0, 0, "09000064828d2eb3"], ["FDA-2016-N-2527-8037", "FDA", "FDA-2016-N-2527", "Exhibit G-4 - Attachment 3 to Second Supplement to Citizen Petition re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-09-07T17:45:09Z", null, 0, 0, "09000064828d1da9"], ["FDA-2016-N-2527-8030", "FDA", "FDA-2016-N-2527", "Exhibit E-2 - Appendix A to Citizen Petion re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T14:23:15Z", null, 0, 0, "09000064828d2eb2"], ["FDA-2016-N-2527-8027", "FDA", "FDA-2016-N-2527", "Exhibit C - re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T13:48:47Z", null, 0, 0, "09000064828d2eaf"], ["FDA-2016-N-2527-8029", "FDA", "FDA-2016-N-2527", "Exhibit E-1 - Citizen Petition dated July 28, 2011 re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T14:11:01Z", null, 0, 0, "09000064828d2eb1"], ["FDA-2016-N-2527-8026", "FDA", "FDA-2016-N-2527", "Exhibit B - re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T13:48:54Z", null, 0, 0, "09000064828d2eae"], ["FDA-2016-N-2527-8033", "FDA", "FDA-2016-N-2527", "Exhibit F-2 - Appendix A to First Supplement to Citizen Petition re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T15:01:24Z", null, 0, 0, "09000064828d1da5"], ["FDA-2016-N-2527-8034", "FDA", "FDA-2016-N-2527", "Exhibit G-1 - Second Supplement to Citizen Petition re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T15:00:28Z", null, 0, 0, "09000064828d1da6"], ["FDA-2016-N-2527-8032", "FDA", "FDA-2016-N-2527", "Exhibit F-1 - First Supplement to Citizen Petition re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T15:01:54Z", null, 0, 0, "09000064828d2eb4"], ["FDA-2016-N-2527-8036", "FDA", "FDA-2016-N-2527", "Exhibit G-3 - Attachment 2 to Second Supplement to Citizen Petition re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T14:59:32Z", null, 0, 0, "09000064828d1da8"], ["FDA-2016-N-2527-8028", "FDA", "FDA-2016-N-2527", "Exhibit D - Analysis of NNN Proposed Rule re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T13:59:26Z", null, 0, 0, "09000064828d2eb0"], ["FDA-2016-N-2527-8035", "FDA", "FDA-2016-N-2527", "Exhibit G-2 - Attachment 1 to Second Supplement to Citizen Petition re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-09T04:00:00Z", 2017, 8, null, null, "2017-08-09T14:59:56Z", null, 0, 0, "09000064828d1da7"], ["FDA-2016-N-2527-8021", "FDA", "FDA-2016-N-2527", "Exhibit A - Reference List re Comment from RAI Services Company", "Supporting & Related Material", "Background Material", "2017-08-07T04:00:00Z", 2017, 8, null, null, "2017-08-07T19:01:38Z", null, 0, 0, "09000064828d2ead"], ["FDA-2016-N-2527-2690", "FDA", "FDA-2016-N-2527", "PRIA Reference 39 - Establishment Registration & Tobacco Product Listing Sample", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:52:12Z", null, 0, 0, "0900006482605576"], ["FDA-2016-N-2527-2651", "FDA", "FDA-2016-N-2527", "PRIA Reference List (3)", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:23:46Z", null, 0, 0, "090000648260527e"], ["FDA-2016-N-2527-2663", "FDA", "FDA-2016-N-2527", "PRIA Reference 12 - The Formation of Nitrosamines in Experimental Tobacco", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:26Z", null, 0, 0, "090000648260535f"], ["FDA-2016-N-2527-2660", "FDA", "FDA-2016-N-2527", "PRIA Reference 9 - Are We Finally Winning the War on Cancer", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:13Z", null, 0, 0, "090000648260550f"], ["FDA-2016-N-2527-2653", "FDA", "FDA-2016-N-2527", "PRIA Reference 2 - Statistical Report - Tobacco Report Symbol, 2015", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:49:44Z", null, 0, 0, "0900006482605508"], ["FDA-2016-N-2527-2655", "FDA", "FDA-2016-N-2527", "PRIA Reference 4 - National Vital Statistical Reports, 2015", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:49:51Z", null, 0, 0, "090000648260550a"], ["FDA-2016-N-2527-2682", "FDA", "FDA-2016-N-2527", "PRIA Reference 31 - U.S. Business Administration", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:43Z", null, 0, 0, "090000648260556e"], ["FDA-2016-N-2527-2664", "FDA", "FDA-2016-N-2527", "PRIA Reference 13 - Code Date Catalog", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:31Z", null, 0, 0, "0900006482605360"], ["FDA-2016-N-2527-2676", "FDA", "FDA-2016-N-2527", "PRIA Reference 25 - Topics for Biological and Biochemical Research", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:20Z", null, 0, 0, "0900006482605560"], ["FDA-2016-N-2527-2688", "FDA", "FDA-2016-N-2527", "PRIA Reference 37 - Occupation Employment Statistics", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:52:04Z", null, 0, 0, "0900006482605574"], ["FDA-2016-N-2527-2652", "FDA", "FDA-2016-N-2527", "PRIA Reference 1 - Combustible and Smokeless Tobacco Use", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:49:36Z", null, 0, 0, "0900006482605507"], ["FDA-2016-N-2527-2656", "FDA", "FDA-2016-N-2527", "PRIA Reference 5 - Smoking and Tobacco Use, 2014", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:49:54Z", null, 0, 0, "090000648260550b"], ["FDA-2016-N-2527-2679", "FDA", "FDA-2016-N-2527", "PRIA Reference 28 - Patients Perceived Health Status Following Primary", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:30Z", null, 0, 0, "0900006482605563"], ["FDA-2016-N-2527-2685", "FDA", "FDA-2016-N-2527", "PRIA Reference 34 - Carcinogenic Tobacco Specific N-Nitrosamines in U.S", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:53Z", null, 0, 0, "0900006482605571"], ["FDA-2016-N-2527-2666", "FDA", "FDA-2016-N-2527", "PRIA Reference 15 - Literature Study  N-Nitrosamines in Tobacco Products", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:40Z", null, 0, 0, "0900006482605362"], ["FDA-2016-N-2527-2671", "FDA", "FDA-2016-N-2527", "PRIA Reference 20 - SEER Cancer Statistics Review, 1975-2012", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:00Z", null, 0, 0, "0900006482605367"], ["FDA-2016-N-2527-2658", "FDA", "FDA-2016-N-2527", "PRIA Reference 7 - Raising th Excise Tax on Cigarettes  Effects on Health and the Federal  Budget, 2012", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:05Z", null, 0, 0, "090000648260550d"], ["FDA-2016-N-2527-2680", "FDA", "FDA-2016-N-2527", "PRIA Reference 29 - Reformulation Cost Model FINAL REPORT", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:35Z", null, 0, 0, "0900006482605564"], ["FDA-2016-N-2527-2659", "FDA", "FDA-2016-N-2527", "PRIA Reference 8 - The 2015 Long Term Budget Outlook", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:09Z", null, 0, 0, "090000648260550e"], ["FDA-2016-N-2527-2661", "FDA", "FDA-2016-N-2527", "PRIA Reference 10 - The Cost Effectiveness of Community Based Screening for Oral Cancer", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:18Z", null, 0, 0, "0900006482605510"], ["FDA-2016-N-2527-2675", "FDA", "FDA-2016-N-2527", "PRIA Reference 24 - Regional Convenience Store Markup Percentages", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:17Z", null, 0, 0, "090000648260555f"], ["FDA-2016-N-2527-2683", "FDA", "FDA-2016-N-2527", "PRIA Reference 32 - Statistics of US Businesses 2013", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:46Z", null, 0, 0, "090000648260556f"], ["FDA-2016-N-2527-2691", "FDA", "FDA-2016-N-2527", "PRIA Reference 40 - FDA's Electronic Reading Room - Warning Letters Sample", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:52:16Z", null, 0, 0, "0900006482605577"], ["FDA-2016-N-2527-2662", "FDA", "FDA-2016-N-2527", "PRIA Reference 11 - An Interim Determination of Health Gain from Oral Cancer", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:21Z", null, 0, 0, "090000648260535e"], ["FDA-2016-N-2527-2669", "FDA", "FDA-2016-N-2527", "PRIA Reference 18 - Is Addiction Rational  Theory and Evidence", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:53Z", null, 0, 0, "0900006482605365"], ["FDA-2016-N-2527-2654", "FDA", "FDA-2016-N-2527", "PRIA Reference 3 - Adjusting the Value of a Statistical Life", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:49:47Z", null, 0, 0, "0900006482605509"], ["FDA-2016-N-2527-2684", "FDA", "FDA-2016-N-2527", "PRIA Reference 33 - Tobacco-Specific Nitrosamines in New Tobacco Products", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:50Z", null, 0, 0, "0900006482605570"], ["FDA-2016-N-2527-2668", "FDA", "FDA-2016-N-2527", "PRIA Reference 17 - Tobacco and the Economy  Farms, Jobs and", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:49Z", null, 0, 0, "0900006482605364"], ["FDA-2016-N-2527-2687", "FDA", "FDA-2016-N-2527", "PRIA Reference 36 - CPI Report 2015 Dec", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:52:00Z", null, 0, 0, "0900006482605573"], ["FDA-2016-N-2527-2692", "FDA", "FDA-2016-N-2527", "PRIA Reference 41 - Informing the NNN Product Standard RIA Memo", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:52:19Z", null, 0, 0, "090000648260558b"], ["FDA-2016-N-2527-2665", "FDA", "FDA-2016-N-2527", "PRIA Reference 14 - Recurrence Rate and Shift in Histopathological Differentiation of", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:36Z", null, 0, 0, "0900006482605361"], ["FDA-2016-N-2527-2667", "FDA", "FDA-2016-N-2527", "PRIA Reference 16 - Prospective Investigation of the Cigarette Smoking", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:44Z", null, 0, 0, "0900006482605363"], ["FDA-2016-N-2527-2670", "FDA", "FDA-2016-N-2527", "PRIA Reference 19 - Report of Nationally Representative Values for the Non", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:56Z", null, 0, 0, "0900006482605366"], ["FDA-2016-N-2527-2657", "FDA", "FDA-2016-N-2527", "PRIA Reference 6 - Smoking and Tobacco Use, 2015", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:50:02Z", null, 0, 0, "090000648260550c"], ["FDA-2016-N-2527-2686", "FDA", "FDA-2016-N-2527", "PRIA Reference 35 - 50 Year Trends in Smoking Related Mortality in the U.S", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:57Z", null, 0, 0, "0900006482605572"], ["FDA-2016-N-2527-2689", "FDA", "FDA-2016-N-2527", "PRIA Reference 38 - Federal Trade Commission Smokeless Tobacco Product Report", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:52:08Z", null, 0, 0, "0900006482605575"], ["FDA-2016-N-2527-2677", "FDA", "FDA-2016-N-2527", "PRIA Reference 26 - The Determination of Tobacco Specific Nitrosamines in", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:24Z", null, 0, 0, "0900006482605561"], ["FDA-2016-N-2527-2678", "FDA", "FDA-2016-N-2527", "PRIA Reference 27 - Valuing Reductions in Fatal Illness Risks", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:27Z", null, 0, 0, "0900006482605562"], ["FDA-2016-N-2527-2681", "FDA", "FDA-2016-N-2527", "PRIA Reference 30 - FDA Labeling Cost Model FINAL", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:38Z", null, 0, 0, "0900006482605565"], ["FDA-2016-N-2527-2693", "FDA", "FDA-2016-N-2527", "PRIA Reference 42 - Crop Production 2014 Summary", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:52:23Z", null, 0, 0, "090000648260558c"], ["FDA-2016-N-2527-2672", "FDA", "FDA-2016-N-2527", "PRIA Reference 21 - The Incentives Created by a Harm Reduction Approach", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:03Z", null, 0, 0, "090000648260555c"], ["FDA-2016-N-2527-2673", "FDA", "FDA-2016-N-2527", "PRIA Reference 22 - Proposal for Basic Research on Tobacco Fermentation", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:07Z", null, 0, 0, "090000648260555d"], ["FDA-2016-N-2527-2674", "FDA", "FDA-2016-N-2527", "PRIA Reference 23 - The Value of Health and Longevity", "Supporting & Related Material", "Background Material", "2017-05-23T04:00:00Z", 2017, 5, null, null, "2017-05-23T16:51:13Z", null, 0, 0, "090000648260555e"], ["FDA-2016-N-2527-0259", "FDA", "FDA-2016-N-2527", "Letter from Robert Ellis to FDA", "Other", "Letter(s)", "2017-03-16T04:00:00Z", 2017, 3, "2017-03-16T04:00:00Z", null, "2017-03-16T16:19:44Z", null, 0, 0, "09000064825011b0"], ["FDA-2016-N-2527-0268", "FDA", "FDA-2016-N-2527", "Request to Extend Comment Period from RAI Services Company", "Other", "Request for Extension", "2017-03-16T04:00:00Z", 2017, 3, "2017-03-16T04:00:00Z", null, "2017-03-16T16:34:58Z", null, 0, 0, "0900006482509dbd"], ["FDA-2016-N-2527-0269", "FDA", "FDA-2016-N-2527", "Request to Extend Comment Period from Reason Foundation", "Other", "Request for Extension", "2017-03-16T04:00:00Z", 2017, 3, "2017-03-16T04:00:00Z", null, "2017-03-16T16:35:11Z", null, 0, 0, "090000648250a4d0"], ["FDA-2016-N-2527-0255", "FDA", "FDA-2016-N-2527", "Letter from The Honorable Andy Barr to DHHS", "Other", "Letter(s)", "2017-03-16T04:00:00Z", 2017, 3, "2017-03-16T04:00:00Z", null, "2017-03-16T16:18:58Z", null, 0, 0, "09000064824f3b35"], ["FDA-2016-N-2527-0261", "FDA", "FDA-2016-N-2527", "Request to Extend Comment Period from Cheyenne International, LLC", "Other", "Request for Extension", "2017-03-16T04:00:00Z", 2017, 3, "2017-03-16T04:00:00Z", null, "2017-03-16T16:20:12Z", null, 0, 0, "0900006482504f00"], ["FDA-2016-N-2527-0226", "FDA", "FDA-2016-N-2527", "TAB B 2015-1102 Smokeless NNN Proposed Rule Track Changes re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-31T05:00:00Z", 2017, 1, null, null, "2017-02-07T14:49:58Z", null, 0, 0, "09000064824a3365"], ["FDA-2016-N-2527-0227", "FDA", "FDA-2016-N-2527", "TAB C 2015-1102 Smokeless NNN PRIA as Cleared by OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-31T05:00:00Z", 2017, 1, null, null, "2017-02-07T14:50:06Z", null, 0, 0, "09000064824a3366"], ["FDA-2016-N-2527-0223", "FDA", "FDA-2016-N-2527", "TAB A 2015-1102 Smokeless NNN PRIA as Submitted to OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-31T05:00:00Z", 2017, 1, null, null, "2017-02-07T14:49:33Z", null, 0, 0, "09000064824a3362"], ["FDA-2016-N-2527-0224", "FDA", "FDA-2016-N-2527", "TAB A 2015-1102 Smokeless NNN Proposed Rule as Submitted to OMB  re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-31T05:00:00Z", 2017, 1, null, null, "2017-02-07T14:49:43Z", null, 0, 0, "09000064824a3363"], ["FDA-2016-N-2527-0222", "FDA", "FDA-2016-N-2527", "Memorandum to FDA DDM Tobacco Smokeless NNN Proposed Rule  re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-31T05:00:00Z", 2017, 1, null, null, "2017-02-07T14:49:25Z", null, 0, 0, "09000064824a3361"], ["FDA-2016-N-2527-0225", "FDA", "FDA-2016-N-2527", "TAB B 2015-1102 Smokeless NNN PRIA Track Changes re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-31T05:00:00Z", 2017, 1, null, null, "2017-02-07T14:49:51Z", null, 0, 0, "09000064824a3364"], ["FDA-2016-N-2527-0228", "FDA", "FDA-2016-N-2527", "TAB C 2015-1102 Smokeless NNN Proposed Rule as Cleared by OMB re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-31T05:00:00Z", 2017, 1, null, null, "2017-02-07T14:50:13Z", null, 0, 0, "09000064824a3367"], ["FDA-2016-N-2527-0114", "FDA", "FDA-2016-N-2527", "Reference 107 - Hecht-2016-Exposure and Metabolic Activation B re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:46:36Z", null, 0, 0, "090000648248ec25"], ["FDA-2016-N-2527-0117", "FDA", "FDA-2016-N-2527", "Reference 110 - Stockwell, Impact of Smoking and Smokeless re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:46:50Z", null, 0, 0, "090000648248ec28"], ["FDA-2016-N-2527-0121", "FDA", "FDA-2016-N-2527", "Reference 114 - Lee-2009-Systematic Review of the Relation Bet re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:47:09Z", null, 0, 0, "090000648248ec33"], ["FDA-2016-N-2527-0204", "FDA", "FDA-2016-N-2527", "Reference 198 - Mirvish, 1975, Formation of N-Nitroso Compounds re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:54:38Z", null, 0, 0, "090000648248ecd5"], ["FDA-2016-N-2527-0055", "FDA", "FDA-2016-N-2527", "Reference 48 - Morin, et al, Evolution of Tobacco Specific Ni re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:41:52Z", null, 0, 0, "090000648248ee8b"], ["FDA-2016-N-2527-0092", "FDA", "FDA-2016-N-2527", "Reference 85 - Digard-2013-Multi-Analyte Approach for Determi re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:44:54Z", null, 0, 0, "090000648248eee3"], ["FDA-2016-N-2527-0129", "FDA", "FDA-2016-N-2527", "Reference 122 - Zhou-2013-Smokeless Tobacco and Risk of Head a re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:47:46Z", null, 0, 0, "090000648248f04c"], ["FDA-2016-N-2527-0133", "FDA", "FDA-2016-N-2527", "Reference 126 - Yanovitzky-2000-Effect of Media Coverage and P re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:48:03Z", null, 0, 0, "090000648248f052"], ["FDA-2016-N-2527-0134", "FDA", "FDA-2016-N-2527", "Reference 127 - Cram-2003-The Impact of a Celebrity Promotiona re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:48:08Z", null, 0, 0, "090000648248f053"], ["FDA-2016-N-2527-0197", "FDA", "FDA-2016-N-2527", "Reference 191 - Boffetta, 2005, Smokeless Tobacco Use and Risk of Pancreatic Cancer re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:54:01Z", null, 0, 0, "090000648248f0da"], ["FDA-2016-N-2527-0026", "FDA", "FDA-2016-N-2527", "Reference 19 - Foulds-2008-Is Low-Nicotine Marlboro Snus Real re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:39:29Z", null, 0, 0, "090000648248ede3"], ["FDA-2016-N-2527-0037", "FDA", "FDA-2016-N-2527", "Reference 30 - Brunnemann-1996-Formation and Analysis of Toba re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:40:24Z", null, 0, 0, "090000648248ee03"], ["FDA-2016-N-2527-0043", "FDA", "FDA-2016-N-2527", "Reference 36 - Burton-1994-Relationship Between Tobacco-Speci re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:40:51Z", null, 0, 0, "090000648248ee12"], ["FDA-2016-N-2527-0013", "FDA", "FDA-2016-N-2527", "Reference 6 - Song-2016-Chemical and Toxicological Character re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:38:26Z", null, 0, 0, "090000648248edc9"], ["FDA-2016-N-2527-0067", "FDA", "FDA-2016-N-2527", "Reference 60 - Hatsukami-1988-Topographical Features of Smoke re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:42:53Z", null, 0, 0, "090000648248eebf"], ["FDA-2016-N-2527-0098", "FDA", "FDA-2016-N-2527", "Reference 91 - Brown, Patent US20050043515A1 re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:45:22Z", null, 0, 0, "090000648248eeeb"], ["FDA-2016-N-2527-0106", "FDA", "FDA-2016-N-2527", "Reference 99 - Stepanov, 2005, Tobacco Specific Nitrosamines and re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:45:58Z", null, 0, 0, "090000648248efd3"], ["FDA-2016-N-2527-0131", "FDA", "FDA-2016-N-2527", "Reference 124 - Chakravorty, B,  Cessation Related Perceptions re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:47:54Z", null, 0, 0, "090000648248f04e"], ["FDA-2016-N-2527-0145", "FDA", "FDA-2016-N-2527", "Reference 138 - Song-2009-Perceptions of Smoking-related Risks re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:49:17Z", null, 0, 0, "090000648248f078"], ["FDA-2016-N-2527-0153", "FDA", "FDA-2016-N-2527", "Reference 147 - Hoffmann, 1990,  Advances in Tobacco Carcinogenesis Chapt 3 re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:49:58Z", null, 0, 0, "090000648248ec78"], ["FDA-2016-N-2527-0156", "FDA", "FDA-2016-N-2527", "Reference 150 - Prokopczyk, 1991, A Study of Betel Quid Carcinogenesis re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:50:13Z", null, 0, 0, "090000648248ec7d"], ["FDA-2016-N-2527-0183", "FDA", "FDA-2016-N-2527", "Reference 177 - McIntee-2000-Metabolism of N'-nitrosonornicoti re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:52:53Z", null, 0, 0, "090000648248ecad"], ["FDA-2016-N-2527-0196", "FDA", "FDA-2016-N-2527", "Reference 190 - Definition of cancer slope factor re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:53:56Z", null, 0, 0, "090000648248f0d7"], ["FDA-2016-N-2527-0212", "FDA", "FDA-2016-N-2527", "Reference 206 - Stepanov, et al, Tobacco specific Nitrosamines in Smokeless re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:55:26Z", null, 0, 0, "090000648248f0f8"], ["FDA-2016-N-2527-0008", "FDA", "FDA-2016-N-2527", "Reference 1 - IARC, Monographs on the Evaluation of Carcinogenic Risks re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:37:58Z", null, 0, 0, "090000648248ed71"], ["FDA-2016-N-2527-0078", "FDA", "FDA-2016-N-2527", "Reference 71 - Jitnarin-2015-Tobacco Use Pattern among a Nati re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:43:46Z", null, 0, 0, "090000648248ea81"], ["FDA-2016-N-2527-0079", "FDA", "FDA-2016-N-2527", "Reference 72 - Hecht, 2008, Exposure to Nicotine and Tobacco-specific re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:43:51Z", null, 0, 0, "090000648248ea82"], ["FDA-2016-N-2527-0111", "FDA", "FDA-2016-N-2527", "Reference 104 - Idris, 1995, Toombak Dipping and Cancer of the Oral Cavity re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:46:20Z", null, 0, 0, "090000648248ebd5"], ["FDA-2016-N-2527-0053", "FDA", "FDA-2016-N-2527", "Reference 46 - Staaf, Formation of Tobacco-specific Nitrosami re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:41:42Z", null, 0, 0, "090000648248ee89"], ["FDA-2016-N-2527-0064", "FDA", "FDA-2016-N-2527", "Reference 57 - EPA, Risk Assessment Guidance re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:42:39Z", null, 0, 0, "090000648248eeab"], ["FDA-2016-N-2527-0105", "FDA", "FDA-2016-N-2527", "Reference 98 - Hecht, 2007, Similar Exposure to a Tobacco-sp re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:45:54Z", null, 0, 0, "090000648248efd2"], ["FDA-2016-N-2527-0130", "FDA", "FDA-2016-N-2527", "Reference 123 - Agaku, 2012, Evaluation of Factors Influencing re Tobacco Product Standard for N-Nitrosonornicotine Level in Finished Smokeless Tobacco Products", "Supporting & Related Material", "Background Material", "2017-01-26T05:00:00Z", 2017, 1, null, null, "2017-01-26T22:47:50Z", null, 0, 0, "090000648248f04d"]], "truncated": false, "filtered_table_rows_count": 285, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2016-N-2527"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527", "results": [{"value": "FDA", "label": "FDA", "count": 285, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2016-N-2527", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 276, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Other", "label": "Other", "count": 8, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&document_type=Proposed+Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527", "results": [{"value": 2017, "label": 2017, "count": 285, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&posted_year=2017", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_facet=comment_start_date"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_facet_date=last_modified"}], "next": "2017-01-26T05~3A00~3A00Z,FDA-2016-N-2527-0130", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2016-N-2527&_next=2017-01-26T05~3A00~3A00Z%2CFDA-2016-N-2527-0130&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1116.7588769458234, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}